Dates: November 14, 2026
Location: Shangri-La Guangzhou, China
This session will introduce the four journals of the Alzheimer's & Dementia family: Alzheimer's & Dementia (A&D), Diagnosis,Assessment & Disease Monitoring (DADM), Translational Research & Clinical Interventions (TRCI) and Behavior & Socioeconomics of Aging (BSEA). It will set out how researchers in China can publish in them, review for them and help shape them.
Editors will explain what each journal publishes, how a manuscript moves from submission to decision, what editors look for, and the most common reasons papers are rejected before review. The session will introduce the new Brain Health section, which sits across A&D and BSEA, and will cover the seven special issue calls now open across the family.
Three invitations: share your work, join the peer review community, and bring a global perspective.
The scope, editors, impact and acceptance rates of each journal, and how to submit.
A new section across A&D and BSEA, covering its working definition of brain health and its research agenda.
How review works, what editors look for, how to write a helpful review, and how to join the reviewer pool.
Why research from China strengthens the evidence, and how the journal family is growing internationally.
Seven live calls with deadlines, plus the East Asia spotlight issue as a completed example.
Open discussion with the panel and audience Q&A.